[
  {
    "id": "rn-q-001",
    "scope": ["RN"],
    "medicationId": "rn-001",
    "medication": "Quinidine",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding in a patient taking quinidine requires immediate notification of the provider?",
    "choices": [
      "Mild nausea",
      "Excessive diarrhea",
      "Occasional dizziness",
      "Dry mouth"
    ],
    "correctAnswer": "Excessive diarrhea",
    "rationale": "Excessive diarrhea is a sign of quinidine toxicity and may precede serious cardiac dysrhythmias.",
    "clinicalPearl": "GI symptoms are often the earliest warning sign of quinidine toxicity."
  },
  {
    "id": "rn-q-002",
    "scope": ["RN"],
    "medicationId": "rn-002",
    "medication": "Procainamide",
    "questionType": "select-all-that-apply",
    "stem": "Which findings suggest a potential adverse reaction to procainamide? (Select all that apply.)",
    "choices": [
      "Joint pain",
      "Butterfly-shaped facial rash",
      "Hypotension",
      "Bradycardia",
      "Dry cough"
    ],
    "correctAnswer": [
      "Joint pain",
      "Butterfly-shaped facial rash",
      "Hypotension"
    ],
    "rationale": "Procainamide can cause a lupus-like syndrome and hypotension.",
    "clinicalPearl": "Drug-induced lupus is a well-known complication of procainamide therapy."
  },
  {
    "id": "rn-q-003",
    "scope": ["RN"],
    "medicationId": "rn-003",
    "medication": "Lidocaine",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding is most concerning in a patient receiving IV lidocaine?",
    "choices": [
      "Metallic taste",
      "Mild nausea",
      "Confusion and tremors",
      "Injection site discomfort"
    ],
    "correctAnswer": "Confusion and tremors",
    "rationale": "Neurologic symptoms indicate lidocaine toxicity and may precede seizures.",
    "clinicalPearl": "CNS toxicity occurs before cardiovascular collapse with lidocaine."
  },
  {
    "id": "rn-q-004",
    "scope": ["RN"],
    "medicationId": "rn-005",
    "medication": "Flecainide",
    "questionType": "multiple-choice",
    "stem": "Flecainide is contraindicated in patients with which condition?",
    "choices": [
      "Atrial fibrillation",
      "Structural heart disease",
      "Hypertension",
      "Sinus tachycardia"
    ],
    "correctAnswer": "Structural heart disease",
    "rationale": "Class IC agents increase mortality in patients with structural heart disease.",
    "clinicalPearl": "Class IC antidysrhythmics are powerful but dangerous in damaged myocardium."
  },
  {
    "id": "rn-q-005",
    "scope": ["RN"],
    "medicationId": "rn-007",
    "medication": "Esmolol",
    "questionType": "multiple-choice",
    "stem": "Why is esmolol preferred for short-term rate control in acute settings?",
    "choices": [
      "It has oral availability",
      "It has a long half-life",
      "It has a very short half-life",
      "It causes less hypotension than other beta-blockers"
    ],
    "correctAnswer": "It has a very short half-life",
    "rationale": "Esmolol’s rapid onset and short duration allow quick titration and discontinuation.",
    "clinicalPearl": "Esmolol is ideal when rapid beta-blockade reversal may be needed."
  },
  {
    "id": "rn-q-006",
    "scope": ["RN"],
    "medicationId": "rn-012",
    "medication": "Amiodarone",
    "questionType": "select-all-that-apply",
    "stem": "Which teaching points should be included for a patient starting amiodarone? (Select all that apply.)",
    "choices": [
      "Avoid grapefruit products",
      "Report vision changes",
      "Monitor for thyroid dysfunction",
      "Take medication with high-fat meals",
      "Expect urine discoloration"
    ],
    "correctAnswer": [
      "Avoid grapefruit products",
      "Report vision changes",
      "Monitor for thyroid dysfunction"
    ],
    "rationale": "Amiodarone affects thyroid, eyes, and has major CYP interactions with grapefruit.",
    "clinicalPearl": "Amiodarone affects multiple organ systems—ongoing monitoring is essential."
  }
]

